Prolonged albumin administration in patients with decompensated cirrhosis: the amount makes the difference.

Competing Interests: Conflicts of Interest: G Zaccherini is part of the speakers’ bureau for Octapharma. P Caraceni is part of the speakers’ bureau for Grifols SA, Octapharma AG, Baxalta, Alfa Sigma, Takeda and Kedrion Biopharma, he is consultant for Kedrion Biopharma, he is on the advisory board for Grifols SA and received a research grant from Octapharma AG. M Tufoni has no conflicts of interest to declare.